Diversified Pipeline of Critical Care Products | Citius Pharmaceuticals December 8, 2023 Life Science
Revolutionizing Cancer Treatment With DNA Damage Response Inhibitor Technology – Rakovina Therapeutics | GCFF September 23, 2023 Others
Tumor Targeting and Penetration Technology Platform – Lisata Therapeutics | GCFF June 15, 2023 Life Science
H1 2022 Healthcare and Life Sciences in North America: Market Insights November 29, 2022 Life Science
Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference September 30, 2021 Life Science
Sanofi Unveils First Global Research Institute in China to Develop Innovative Drugs April 14, 2021 Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% February 12, 2021 Life Science
Healthcare Roundup – Merck and Teva in talks to join COVID-19 vaccine production, Aurora Cannabis shares up after FQ2 revenue rides high on medical cannabis strength February 11, 2021 Life Science
Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi February 5, 2021 Life Science
Healthcare Roundup – AstraZeneca COVID-19 shot is only for those aged 18-64 in Germany, Hims & Hers Health soars after Cathie Wood’s ETF discloses stake January 28, 2021 Life Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab data January 19, 2021 Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September;Grifols to trial new immunoglobulin therapy against COVID-19 January 18, 2021 Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst January 15, 2021 Life Science
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivir January 14, 2021 Life Science
Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout January 12, 2021 Life Science